HighTower Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,000
Closed -$7K 3275
2021
Q2
$7K Buy
+18,000
New +$664K ﹤0.01% 3016
2021
Q1
Sell
-233
Closed -$53K 3131
2020
Q4
$53K Buy
+233
New +$10.7K ﹤0.01% 2404

Other funds holding GDRX

HighTower Advisors's GDRX Position: Q2 2026 in Review

HighTower Advisors reduced its GoodRx Holdings (GDRX) stake by 0.94% in Q2 2026, selling an estimated $1.38K and leaving 57,302 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #3579.

HighTower Advisors first reported a position in GDRX in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.67M in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • HighTower Advisors held 57,302 shares of GoodRx Holdings worth $165K as of Q2 2026.
  • HighTower Advisors sold 542 GoodRx Holdings shares in Q2 2026, an estimated $1.38K.
  • GoodRx Holdings made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3579 holding.
  • HighTower Advisors first reported a position in GoodRx Holdings in Q4 2020 and has held it in 15 quarters since.
  • HighTower Advisors's GoodRx Holdings position peaked at $2.67M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.